Synthetic-rating coverage uses the latest fiscal year's EBIT over the SAME year's interest expense (no trailing-twelve-month interest could be formed from the quarterly tagging) — a matched-window ratio, never TTM earnings over annual interest.
Cash-flow figures use the latest fiscal year: this filer tags quarterly cash flows year-to-date only and the missing discrete quarters could not be derived (irregular fiscal quarters or a tagging change), so no four consecutive quarters exist to sum.
No four consecutive quarters could be summed for EPS (Diluted), Interest Expense; these figures use the latest fiscal year, not a trailing twelve months.
Some figures named '(TTM)' on this payload are the latest FISCAL YEAR, not a trailing twelve months — eps_ttm (fiscal year ended 2025-06-30). No four consecutive quarters could be summed for them — for an IFRS 20-F filer that is every income-statement line (no quarterly income statement is tagged to EDGAR at all); for a US filer it is usually one line the quarterly tagging skips. Each field's own basis is on field_basis.
full derived coverage requires a plan
Output of a disclosed model — assumptions may be wrong. Research, not investment advice. See the Disclaimer.
— Months · distinct values (the real sample size).
Metric
Today
Own median
Own range
%ile
z
Sector med.
mo · distinct
24.60×
15.55×
74th
−0.15σ
24.86×
72 · 71
26.6%
24.8%
70th
+0.60σ
−36.9%
60 · 5
19.7%
15.2%
90th
+1.52σ
−15.4%
60 · 5
13.5%
13.5%
43rd
+0.14σ
−21.3%
72 · 6
12.1%
30.5%
54th
−0.11σ
5.1%
141 · 141
30.2%
—
no band (35 mo · 3 distinct)
—
—
8.4%
35 · 3
16.6%
—
no band (35 mo · 3 distinct)
—
—
9.0%
35 · 3
Market Cap
$209.67M
not reconstructed — market cap was removed from the historical pass (never a ranking factor, and a reconstructed share count carries look-ahead risk). The single stored value is the forward-captured snapshot, not a series.
Own median 15.55× × $2.67 = $41.51vs the $65.67 close · earnings held constant
Own multiple
P/E
Implied price
vs close
10th percentile
10.08×
$26.90
−59.0%
25th percentile
12.57×
$33.55
−48.9%
median
15.55×
$41.51
−36.8%
75th percentile
21.40×
$57.12
−13.0%
90th percentile
66.40×
$177.28
+170.0%
today
24.60×
$65.67
—
Reference computation · 72 monthly P/E observations in Full · EPS basis FY2025 EPS (Diluted) $2.67 · close $65.67 (2026-08-21)ⓘ
Not a forecast: each row re-prices today's filed earnings at a multiple this company itself once traded at. It abstains rather than guess on a loss year or a broken per-share basis.
Every month uses only what was filed by then, split-adjusted. Delisted names are absent and a trough year can throw one huge reading, so read the median, not the edges.
Percentile through time (point-in-time cohort)
Loading the monthly cohort placement…
▸Comp setname your own peers — pick a pool or add tickers
PDEX is not drawn here: its newest pool year (CY2024) differs from the industry’s (CY2025), so its 0.0% is a different year’s share.
Growth, restated as sharewhere each pace has to END UP, by 2029
Its own realised pace0.0% → 0.0%
The pace the price requires— The growth today's price requires (our reverse-DCF) is a Pro metric — the realized-pace runway above is free.
PDEX share over time6 published years
Calendar year
2019
2020
2021
2022
2023
2024
Share of covered pool
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
year: this company's newest published… · share_5y: 2019's pool shares 79… · coverage: 151 of the 152 members that…
Share of covered industry revenue · n=160 in Health Care Equipment & Supplies · CY2024 pool · built 2026-08-22 not market shareⓘ
Covered filers only, not market share — private and uncovered companies are missing, so every share here reads high. Years are FX-converted and published only once most of the pool has filed.
